| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,085 |
1,038 |
$102K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,725 |
1,653 |
$94K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,038 |
1,017 |
$52K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
241 |
238 |
$20K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
269 |
262 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
195 |
192 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
103 |
103 |
$4K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
323 |
320 |
$3K |
| 0002A |
|
44 |
44 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
160 |
160 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
69 |
69 |
$839.32 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
78 |
39 |
$727.87 |
| 96127 |
|
41 |
38 |
$657.28 |